Image Credit: Canva Stock Photo Neurona Therapeutics has reached a major milestone in the development of its stem cell approach to treating epilepsy. The company recently announced that the first patient has been dosed in a Phase 1/2 clinical trial evaluating NRTX-1001, a cell therapy for adults whose epilepsy affects both sides of the brain … Continue reading Neurona Doses First Patient in CIRM-Funded Bilateral Epilepsy Cell Therapy Trial
Author: Esteban Cortez
Two CIRM-funded research projects receive RMAT designation from FDA
The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to two research projects funded by the California Institute for Regenerative Medicine (CIRM). RMAT is a fast-track designation that can help speed up the development, review, and potential approval of treatments for serious or life-threatening diseases. The first RMAT designation … Continue reading Two CIRM-funded research projects receive RMAT designation from FDA
How California is advancing our understanding of Alzheimer’s disease using stem cells
Over 14,000 people in Fresno County are living with Alzheimer's, and it’s estimated that more than 720,000 people are living with the brain disorder in California. That’s why the California Institute for Regenerative Medicine (CIRM)—a state of California agency dedicated to funding regenerative medicine research—joined the Alzheimer's Association Walk to End Alzheimer’s in Fresno/Madera to … Continue reading How California is advancing our understanding of Alzheimer’s disease using stem cells
Inaugural UC San Diego Gene Therapy Initiative Symposium is fueling progress in the field
There was no shortage of enthusiasm at the inaugural UC San Diego Gene Therapy Initiative Symposium hosted at the Roth Auditorium at the prestigious Sanford Consortium, where researchers, clinicians, academia, industry, and patient advocates shared discoveries in gene therapy, a modern-day treatment that’s revolutionizing medicine.CIRM was a platinum sponsor of the event.The gene therapy field … Continue reading Inaugural UC San Diego Gene Therapy Initiative Symposium is fueling progress in the field
California high schoolers “ignite innovation” at 2024 SPARK conference
More than 100 student scientists from around California showcased their excitement for regenerative medicine and stem cell research at this year’s annual CIRM SPARK Conference in the sunny Inland Empire. Hosted by UC Riverside from Aug. 5-6 at the Riverside Convention Center, this year’s event showcased the extraordinary talent and enthusiasm of high school students … Continue reading California high schoolers “ignite innovation” at 2024 SPARK conference
How CIRM’s high school internship program inspired this scientist’s career path
Photos courtesy of Rashi Ranjan Each year, interns and trainees from the California Institute for Regenerative Medicine (CIRM) education and training programs celebrate achievements, whether that’s making new discoveries in their cell and gene therapy research or advancing to the next phase of their professional journey. This summer, Rashi Ranjan—a former SPARK high school intern—is … Continue reading How CIRM’s high school internship program inspired this scientist’s career path
CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign
April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease. What is Parkinson’s Disease? Parkinson's disease (PD) is a neurodegenerative disease that affects nearly 1 million people in the United States … Continue reading CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign
CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
Dr. Vito Imbasciani was sworn in as the new Chair of the Board of the California Institute for Regenerative Medicine (CIRM) at its March meeting. Imbasciani (pictured above at left) was elected to the six-year term at CIRM’s January Board meeting. He will replace outgoing chair Jonathan Thomas, who has served in the position since 2011. “My experience … Continue reading CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
Investing in stem cell and gene therapy treatments for HIV
A recent article in Nature shared the news about a 53-year-old man in Germany who was declared free of HIV after receiving virus-resistant cells. The man—referred to as the “Düsseldorf patient”—was diagnosed with acute myeloid leukemia and underwent a stem cell transplant in 2013 that replaced his bone marrow cells with HIV-resistant stem cells from … Continue reading Investing in stem cell and gene therapy treatments for HIV
CIRM board member Ysabel Duron appointed to National Cancer Advisory Board by President Biden
Ysabel Duron is an award-winning journalist, patient advocate, cancer survivor and board member of the California Institute for Regenerative Medicine (CIRM). Her list of achievements continues to grow, as President Biden has appointed Duron to National Cancer Advisory Board (NCAB), which plays an important role in setting the course for the national cancer research program. … Continue reading CIRM board member Ysabel Duron appointed to National Cancer Advisory Board by President Biden
The Stem Cellar 